Table 4 Adverse events and clinical outcomes of prolonged continuous prone positioning
Total (n = 417) | Group A (n = 191) | Group B (n = 128) | Group C (n = 98) | p-value | |
|---|---|---|---|---|---|
Adverse events, n (%) | |||||
Pressure soresa, n (%) | 97 (23.9) | 27 (14.2) | 29 (23.6) | 41 (44.1) | < 0.001 |
Pressure sores up to day 7b, n (%) | 147 (36.2) | 63 (33.2) | 41 (33.3) | 43 (46.2) | 0.077 |
Vascular catheters displacementa, n (%) | 11 (2.7) | 4 (2.1) | 3 (2.4) | 4 (4.3) | 0.535 |
Non-scheduled extubationa, n (%) | 17 (4.2) | 8 (4.2) | 4 (3.3) | 5 (5.4) | 0.465 |
Endotracheal obstructiona, n (%) | 14 (3.4) | 5 (2.6) | 4 (3.3) | 5 (5.4) | 0.728 |
Clinical outcomes | |||||
90-day mortality, n (%) | 151 (36.2) | 58 (30.4) | 46 (35.9) | 47 (48) | 0.014 |
ICU-mortality, n (%) | 131 (31.4) | 53 (27.8) | 37 (28.9) | 41 (41.8) | 0.043 |
In-hospital mortality, n (%) | 139 (33.3) | 54 (28.3) | 39 (30.5) | 46 (46.9) | 0.005 |
Tracheostomy, n (%) | 80 (19.6) | 20 (10.7) | 24 (19) | 36 (37.5) | < 0.001 |
Time on MV (days), median (IQR) | 15 (10–22) | 12 (8- 19) | 16 (11–23) | 21 (13–32) | < 0.001 |
ICU LoS (days), median (IQR) | 17 (13–25) | 15 (11–22) | 18 (13–27) | 22 (15–32) | < 0.001 |
Hospital LoS (days), median (IQR) | 24 (16–38) | 21 (14–33) | 27 (16–40) | 29 (16–50) | 0.001 |